Treatment of lentigo maligna with tazarotene 0.1% gel

Ketty Peris, S Chimenti, Am Carrozzo, L Citarella, C De Felice

Risultato della ricerca: Contributo in rivistaArticolo in rivista

12 Citazioni (Scopus)

Abstract

We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.
Lingua originaleEnglish
pagine (da-a)101-103
Numero di pagine3
RivistaJournal of the American Academy of Dermatology
Volume50
DOI
Stato di pubblicazionePubblicato - 2004

Keywords

  • Aged
  • Aged, 80 and over
  • Dermatologic Agents
  • Female
  • Gels
  • Humans
  • Hutchinson's Melanotic Freckle
  • Male
  • Nicotinic Acids

Fingerprint

Entra nei temi di ricerca di 'Treatment of lentigo maligna with tazarotene 0.1% gel'. Insieme formano una fingerprint unica.

Cita questo